Why the study?
Redo tricuspid valve replacement carries high surgical operative mortality, making transcatheter valve-in-valve replacement a viable alternative.
Transcatheter tricuspid valve-in-valve replacement represents a potential therapeutic option for pregnant patients with severe bioprosthetic stenosis who face high surgical mortality.
Supports feasibility of transcatheter tricuspid valve-in-valve in pregnant patients with bioprosthetic stenosis; leaves open need for safety data in larger cohorts.
Redo tricuspid valve replacement has high surgical operative mortality. Transcatheter valve-in-valve provides a viable option for valve replacement. We discuss the decision-making process involved in performing transcatheter tricuspid valve-in-valve replacement in a 23-week pregnant woman with multiple comorbidities and symptomatic severe bioprosthetic stenosis. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Adejumo et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: